Form 13-F position report

THE BEAUTY HEALTH COMPANY CL A

Reported by THE BANK OF NEW YORK MELLON CORPORATION

SKIN CUSIP 88331L108 Manager CIK 0001390777

Reported 373,738 shares, up 36,138 (10.7%) from the prior quarter.

Reported value -15.7%; share count 10.7% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 373,738 Quarter-end amount reported
Reported value $4,807,000 Fair value at quarter end
Consecutive quarters held 5 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 8872000
2022-03-31 5699000
2022-06-30 4807000
2022-09-30 5025000
2022-12-31 2854343
2023-03-31 3669963
2023-06-30 2287286
2023-09-30 1646078
2023-12-31 860216
2024-03-31 1237779
2024-06-30 668368
2024-09-30 405702
2024-12-31 419194
2025-03-31 310920
2025-06-30 580823
2025-09-30 616603
2025-12-31 420894
2026-03-31 258589
2026-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for THE BEAUTY HEALTH COMPANY CL A held by THE BANK OF NEW YORK MELLON CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 0 -290,550 (-100.0%) 0 $0 2026-08-06
Q1 2026 Reduced 290,550 -12,251 (-4.0%) < 0.01% $258,589 2026-05-05
Q4 2025 Reduced 302,801 -7,050 (-2.3%) < 0.01% $420,894 2026-02-10
Q3 2025 Added 309,851 +5,755 (1.9%) < 0.01% $616,603 2025-11-03
Q2 2025 Added 304,096 +72,066 (31.1%) < 0.01% $580,823 2025-08-05
Q1 2025 Reduced 232,030 -31,614 (-12.0%) < 0.01% $310,920 2025-04-29
Q4 2024 Reduced 263,644 -18,094 (-6.4%) < 0.01% $419,194 2025-02-04
Q3 2024 Reduced 281,738 -66,370 (-19.1%) < 0.01% $405,702 2024-11-12
Q2 2024 Added 348,108 +69,329 (24.9%) < 0.01% $668,368 2024-07-25
Q1 2024 Added 278,779 +2,182 (0.8%) < 0.01% $1,237,779 2024-04-25
Q4 2023 Added 276,597 +3,162 (1.2%) < 0.01% $860,216 2024-01-29
Q3 2023 Added 273,435 +163 (0.1%) < 0.01% $1,646,078 2023-10-24
Q2 2023 Reduced 273,272 -17,303 (-6.0%) < 0.01% $2,287,286 2023-08-03
Q1 2023 Reduced 290,575 -23,089 (-7.4%) < 0.01% $3,669,963 2023-05-09
Q4 2022 Reduced 313,664 -112,566 (-26.4%) < 0.01% $2,854,343 2023-02-14
Q3 2022 Added 426,230 +52,492 (14.0%) < 0.01% $5,025,000 2022-11-14
Q2 2022 Added 373,738 +36,138 (10.7%) < 0.01% $4,807,000 2022-08-15
Q1 2022 Reduced 337,600 -29,655 (-8.1%) < 0.01% $5,699,000 2022-05-11
Q4 2021 Added 367,255 +23,705 (6.9%) < 0.01% $8,872,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

184 managers reported THE BEAUTY HEALTH COMPANY CL A for Q2 2022.

Managers reporting THE BEAUTY HEALTH COMPANY CL A in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 22,594,751 +5,044 0.03% $290,568,498 5 qtrs
VANGUARD GROUP INC Added 9,684,147 +157,052 < 0.01% $124,539,000 5 qtrs
JANUS HENDERSON GROUP PLC Added 9,469,576 +3,715,879 0.08% $121,780,000 5 qtrs
BAMCO INC NY Added 7,168,184 +2,929,313 0.3% $92,183,000 5 qtrs
BlackRock Inc Reduced 6,452,166 -1,326,223 < 0.01% $82,976,000 5 qtrs
WILLIAM BLAIR INVESTMENT MANAGEMENT LLC Reduced 6,048,627 -83,539 0.29% $77,785,000 5 qtrs
Redmile Group LLC Reduced 5,186,348 -118,157 2.55% $66,696,000 5 qtrs
Luxor Capital Group LP Added 3,705,481 +2,060,007 2.08% $47,652,000 5 qtrs
Soleus Capital Management L P Added 3,276,037 +3,048,425 6.57% $42,130,000 5 qtrs
Senvest Management LLC Added 2,709,347 +557,011 1.19% $34,842,000 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
332,763
Shared
0
None
40,975

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.